BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Diagnosis
21 results:

  • 1. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
    Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
    Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological features and differential diagnosis of gastric metastases.
    Chen W; Liu C; Liu Y; Yuan J; Wang Z
    World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
    Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach.
    Fichtner A; Richter A; Filmar S; Kircher S; Rosenwald A; Küffer S; Nettersheim D; Oing C; Marx A; Ströbel P; Bremmer F
    Histopathology; 2022 Jan; 80(2):381-396. PubMed ID: 34506648
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
    Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
    Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Social rights claims for malignant melanoma patients : Providing patient information in german dermatological practices].
    Zander N; Krensel M; Schäfer I; Weyergraf A; Mohr P; Strömer K; Augustin M
    Hautarzt; 2019 Oct; 70(10):804-810. PubMed ID: 31267179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Pathologic features on gonadal changes of sexual developmental disorders in children].
    Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
    [No Abstract]    [Full Text] [Related]  

  • 8. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
    Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
    J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
    Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
    Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Many postchemotherapy sarcomatous tumors in patients with testicular germ cell tumors are sarcomatoid yolk sac tumors: a study of 33 cases.
    Howitt BE; Magers MJ; Rice KR; Cole CD; Ulbright TM
    Am J Surg Pathol; 2015 Feb; 39(2):251-9. PubMed ID: 25229769
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac.
    Nogales FF; Quiñonez E; López-Marín L; Dulcey I; Preda O
    Histopathology; 2014 Jul; 65(1):51-9. PubMed ID: 24444105
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunohistochemical studies of metastatic germ-cell tumors in retroperitoneal dissection specimens: a sensitive and specific panel.
    Bai S; Wei S; Pasha TL; Yao Y; Tomaszewski JE; Bing Z
    Int J Surg Pathol; 2013 Aug; 21(4):342-51. PubMed ID: 23893437
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Metastatic medulloblastoma in an adolescent with Simpson-Golabi-Behmel syndrome.
    Thomas M; Enciso V; Stratton R; Shah S; Winder T; Tayeh M; Roeder E
    Am J Med Genet A; 2012 Oct; 158A(10):2534-6. PubMed ID: 22893378
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
    Schubert A
    Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma].
    Nishimura Y; Nakatsura T; Senju S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):383-91. PubMed ID: 18974622
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases.
    He H; Fang W; Liu X; Weiss LM; Chu PG
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):40-6. PubMed ID: 18813128
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Glypican 3: a novel marker in testicular germ cell tumors.
    Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
    Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.
    Ikuta Y; Nakatsura T; Kageshita T; Fukushima S; Ito S; Wakamatsu K; Baba H; Nishimura Y
    Clin Cancer Res; 2005 Nov; 11(22):8079-88. PubMed ID: 16299239
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
    Nakatsura T; Nishimura Y
    BioDrugs; 2005; 19(2):71-7. PubMed ID: 15807627
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of glypican-3 as a novel tumor marker for melanoma.
    Nakatsura T; Kageshita T; Ito S; Wakamatsu K; Monji M; Ikuta Y; Senju S; Ono T; Nishimura Y
    Clin Cancer Res; 2004 Oct; 10(19):6612-21. PubMed ID: 15475451
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.